MedTrace Logo

Electroacupoint for Diminutive Milk Production

NCT06590805 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Conditions

  • Physical Therapy
  • Electrotherapy
  • Dietary Modification

Interventions

PROCEDURE

Electrotherapy using Chattanooga stimulation unit

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

DIETARY_SUPPLEMENT

Balanced Diet using domperidone drug, iron, and folic acid supplementation.

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Sponsors & Collaborators

  • Haytham Ibrahim Morsi

    lead OTHER

Principal Investigators

  • Haytham I Morsi, M.Sc. · Kafrelsheikh University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-01-01
Completion
2025-06-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590805 on ClinicalTrials.gov